Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.

Recs

0
Player Avatar avi417 (67.99) Submitted: 10/19/2006 12:05:05 PM : Outperform Start Price: $14.74 SLXP Score: +242.21

great pipeline and some hot products coming to market i.e. xifaxan for crohn's

Featured Broker Partners


Advertisement